NContact scores 510(k) clearance for next-gen cardiac system

01/24/2013 | MassDevice.com (Boston)

The FDA has cleared nContact to market EPi-Sense, a next-generation version of the company's VisiTrax heart ablation system. The newly cleared technology comes with advanced sensors, which transmit electrical signals to help electrophysiologists position the device better when performing cardiac ablation surgery.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr Statistician I (US/TB/00/0028/SL)
Abbott
Santa Clara, CA
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA